Accu-Chek Solo micropump
Roche Diabetes Care
A small, flat, tubeless micropump with a wireless controller and interoperable pump clearance. CE-marked in Europe and FDA-cleared, but real-world availability is concentrated outside the US.
The scorecard
FDA cleared as an alternate-controller-enabled interoperable insulin pump able to communicate with compatible digitally connected devices.[1]
Regulatory clearance and years of selected-market use support basic pump function, though large contemporary outcome datasets are limited.[2]
Tubeless micropump worn flat on the body, with detachable pump holder/reservoir architecture.[3]
Micropump form factor trades reservoir size for small wearability; capacity is less compelling than 300-unit patch pumps.[3]
CE-marked and supported in selected European/UK markets, but US commercial availability remains unclear despite FDA clearance.[1]
The full picture
Solo is easy to miss because it is not a US-mainstream AID brand, but it matters to pump completeness: a tubeless Roche micropump, CE-marked and FDA-cleared as interoperable pump technology. Its weakness is not the basic design; it is ecosystem visibility and uneven market availability compared with Omnipod, Tandem, Medtronic or Ypsomed.
Sources
- [1]FDA 510(k): Accu-Chek Solo micropump system with interoperable technology (K213134) · regulatory
- [2]Roche receives CE Mark for Accu-Chek Solo micropump system · manufacturer · 2018-07-23
- [3]Accu-Chek UK support: Accu-Chek Solo micropump · manufacturer